Pure Global

SARS-CoV-2 Nucleic Acid Detection Kit - India CDSCO Medical Device Registration

SARS-CoV-2 Nucleic Acid Detection Kit is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2020/000383_145c6973baea1c6f53b3548a1731e3a3_e50a9a6aa54cf3aef48d89dea1975eee. This device is marketed under the brand name Immunofluorescence. The license holder is BIODX HEALTHCARE, and it is classified as Device Class Class C. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class C
SARS-CoV-2 Nucleic Acid Detection Kit
UID: IMP/IVD/2020/000383_145c6973baea1c6f53b3548a1731e3a3_e50a9a6aa54cf3aef48d89dea1975eee

Brand Name

Immunofluorescence

License Holder

BIODX HEALTHCARE

Device Class

Class C

Approving Authority

CDSCO

Product Information

This kit is used inqualitative detection in vitro of SARS-CoV-2 RNA in sputum, throat swab, alveolar lavage fluids specimens from suspected COVID-19 cases, suspected clustered cases, other cases requiring SARS-CoV-2 diagnosis or differential diagnosis

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing